Glenmede Trust Co. NA Boosts Stock Position in The Allstate Co. (NYSE:ALL)

Glenmede Trust Co. NA raised its holdings in The Allstate Co. (NYSE:ALL) by 5.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 108,869 shares of the insurance provider’s stock after buying an additional 5,911 shares during the period. Glenmede Trust Co. NA’s holdings in Allstate were worth $20,647,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BDF Gestion purchased a new position in Allstate in the 2nd quarter worth about $3,051,000. OFI Invest Asset Management bought a new stake in shares of Allstate during the second quarter valued at approximately $476,000. Diversified Trust Co boosted its holdings in shares of Allstate by 505.3% in the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after purchasing an additional 6,614 shares during the period. Cetera Investment Advisers grew its stake in Allstate by 351.6% in the first quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock worth $11,284,000 after purchasing an additional 50,780 shares in the last quarter. Finally, Eagle Asset Management Inc. grew its stake in Allstate by 38.0% in the third quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock worth $2,067,000 after purchasing an additional 2,888 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Trading Up 0.2 %

Allstate stock opened at $208.19 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market cap of $55.13 billion, a PE ratio of 13.48, a price-to-earnings-growth ratio of 1.80 and a beta of 0.48. The stock has a 50-day moving average of $192.34 and a two-hundred day moving average of $178.57. The Allstate Co. has a one year low of $134.17 and a one year high of $209.88.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue was up 14.7% on a year-over-year basis. During the same period last year, the firm posted $0.81 EPS. On average, research analysts anticipate that The Allstate Co. will post 16.07 EPS for the current fiscal year.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Insider Activity

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ALL shares. Roth Mkm reaffirmed a “buy” rating and set a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. Barclays lifted their price objective on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. Piper Sandler increased their target price on shares of Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a report on Tuesday. TD Cowen boosted their price target on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Finally, Evercore ISI increased their price objective on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $217.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.